New hope for kidney cancer: experimental combo enters human testing
Disease control
Recruiting now
This study tests a new drug (HC-7366) combined with an approved drug (belzutifan) in about 80 adults with advanced or spreading kidney cancer. The goal is to find the safest dose and see if the combination shrinks tumors. Participants must have clear cell kidney cancer that canno…
Phase: PHASE1 • Sponsor: HiberCell, Inc. • Aim: Disease control
Last updated May 06, 2026 16:02 UTC